abstract |
A composition comprising a kinase inhibitor compound, for example N- (4- {4-amino-7- [1- (2-hydroxyethyl) -1H-pyrazol-4-iI] tie no [3,2-c] pyridin-3-yl} phenyl) -N '- (3-fluorophenyl) urea, in a mixture comprising (a) a pharmaceutically acceptable water soluble polymer carrier and (b) a pharmaceutically acceptable surfactant. The composition is suitable for dilution with an IV solution for administration to an individual in need thereof for treatment of a cancer. |